A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity (clinicaltrials.gov) - Sep 24, 2026 - P1 | N=70 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
|